Abstract
Background To screen the circular RNAs (circRNA) influencing matrix metalloproteinase-9 (MMP9) through competing endogenous RNA (ceRNA) network and evaluate the prognostic value of these circRNAs for acute ischemic stroke. Methods A total of 220 ischemic stroke patients and 62 healthy subjects were included in this study. RNA was isolated from blood collected in PAXgene tubes. Illumina sequencing, quantitative real-time polymerase chain reaction (qRT-PCR) validation and luciferase reporter assay were explored to construct and verify the existence of circRNA-microRNA-MMP9 network. The 215 ischemic stroke patients were recruited in a prognostic cohort. They were prospectively followed up for 3 months after stroke onset and a poor functional outcome was defined as a major disability or death. Results After illumina sequencing, six circRNAs were predicted to bind microRNAs and then regulate MMP9 mRNA. QRT-PCR showed that only circSKA3 was significantly increased in ischemic stroke patients compared to healthy controls and positively associated with MMP9 mRNA expression. Luciferase reporter assay further verified a direct interaction between circSKA3, MMP9 and hsa-miR-6796-5p. Patients in the top tertile of circSKA3 had a 2.672-fold (PP for trend=0.016). The outcome was predicted by circSKA3 with area under the receiver operating characteristic curve at 0.614 (P=0.004). Conclusions CircSKA3 functioned as a ceRNA for hsa-miR-6796-5p to aggravate the progression of ischemic stroke via targeting MMP9. Baseline circSKA3 was positively associated with poor outcomes of ischemic stroke. CircSKA3 may be a potential biomarker or therapeutic target in ischemic stroke.

This publication has 19 references indexed in Scilit: